[1] |
Leukemia and Lymphoma Group, Society of Hematology. Chinese expert consensus on the diagnosis and treatment of eosinophilia(2017)[J]. Chin J Hematol, 2017, 38(7): 561-565. DOI: 10.3760/cma.j.issn.0253-2727.2017.07.001.
中华医学会血液学分会白血病淋巴瘤学组. 嗜酸粒细胞增多症诊断与治疗中国专家共识(2017年版)[J]. 中华血液学杂志, 2017, 38(7): 561-565. DOI: 10.3760/cma.j.issn.0253-2727.2017.07.001.
|
[2] |
SHOMALI W, GOTLIB J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management[J]. Am J Hematol, 2019, 94(10): 1149-1167. DOI: 10.1002/ajh.25617.
|
[3] |
SCHUSTER B, ZINK A, EYERICH K. Medical algorithm: Diagnosis and treatment of hypereosinophilic syndrome[J]. Allergy, 2020, 75(11): 3003-3006. DOI: 10.1111/all.14368.
|
[4] |
VALENT P, KLION AD, HORNY HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes[J]. J Allergy Clin Immunol, 2012, 130(3): 607-612. e9. DOI: 10.1016/j.jaci.2012.02.019.
|
[5] |
SCHREIBER A, LEBLANC M, THIBEAULT MM, et al. Generalized recalcitrant pruritus as the presenting manifestation of hypereosinophilic syndrome[J]. J Cutan Med Surg, 2016, 20(4): 346-348. DOI: 10.1177/1203475416629603.
|
[6] |
ZHUANG E, ZHENG ZY, MAO W, et al. Right ventricular apical obstruction in a patient with hypereosinophilia: Löffler endocarditis[J]. Heart Lung, 2015, 44(2): 165-169. DOI: 10.1016/j.hrtlng.2014.11.003.
|
[7] |
KUANG FL. Approach to patients with eosinophilia[J]. Med Clin North Am, 2020, 104(1): 1-14. DOI: 10.1016/j.mcna.2019.08.005.
|
[8] |
WU H, ZHENG X, ZHU L, et al. A case of eosinophilia mainly manifesting as liver injury[J]. J Clin Hepatol, 2022, 38(4): 883-885. DOI: 10.3969/j.issn.1001-5256.2022.04.027.
吴昊, 郑欣, 朱磊, 等. 以肝损害为主要表现的嗜酸粒细胞增多症1例报告[J]. 临床肝胆病杂志, 2022, 38(4): 883-885. DOI: 10.3969/j.issn.1001-5256.2022.04.027.
|